VERVE THERAPEUTICS INC(NASDAQ:VERV) stock News

VERV Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Eli Lilly and Company - Mentions: LLY

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

a month ago - By: Eli Lilly and Company - Mentions: LLY

Lilly and Verve announce expiration of Verve tender offer

a month ago - By: Yahoo Finance - Mentions: LLY

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

a month ago - By: MarketBeat - Mentions: URGN NKTR

3 Bullish Biotech Stocks With Explosive Growth Trends

2 months ago - By: Benzinga

5 Analysts Assess Verve Therapeutics: What You Need To Know

2 months ago - By: The Motley Fool - Mentions: LLY

Why Verve Therapeutics Stock Is Skyrocketing Today

a month ago - By: MarketBeat - Mentions: KSS NTLA GOGO LLY ...

Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook

2 months ago - By: Yahoo Finance - Mentions: LLY

Verve Therapeutics, Inc. (VERV): A Bull Case Theory

2 months ago - By: Brodsky & Smith LLC - Mentions: SAGE CTLP NYSE LLY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

2 months ago - By: Benzinga - Mentions: RGC SAGE

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

2 months ago - By: The Motley Fool - Mentions: LLY

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week

2 months ago - By: Halper Sadeh LLC - Mentions: CTLP CVAC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

2 months ago - By: Kahn Swick & Foti, LLC

VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV

2 months ago - By: Yahoo Finance - Mentions: LLY VZ

Verve Therapeutics downgraded to Hold from Buy at Canaccord

2 months ago - By: Halper Sadeh LLC - Mentions: SAGE CTLP SOAR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

2 months ago - By: Brodsky & Smith LLC - Mentions: SAGE CTLP SOAR LLY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

2 months ago - By: Halper Sadeh LLC

VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders

2 months ago - By: Yahoo Finance - Mentions: LLY

Why Verve Therapeutics Stock Is Skyrocketing Today

2 months ago - By: Yahoo Finance - Mentions: LLY

Eli Lilly Strikes up to $1.3 Billion Deal to Buy Verve Therapeutics

2 months ago - By: Investor's Business Daily - Mentions: LLY NTLA EDIT CRSP ...

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

2 months ago - By: Ademi & Fruchter LLP

Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

2 months ago - By: Yahoo Finance - Mentions: LLY KHC BEAM NTLA

Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B

2 months ago - By: Yahoo Finance - Mentions: JBL LZB UBS BAC

VERVE THERAPEUTICS INC (VERV) Stock News

VERV Latest News, Press Relases and Analysis

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Lilly and Verve announce expiration of Verve tender offer

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

3 Bullish Biotech Stocks With Explosive Growth Trends

5 Analysts Assess Verve Therapeutics: What You Need To Know

Why Verve Therapeutics Stock Is Skyrocketing Today

Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook

Verve Therapeutics, Inc. (VERV): A Bull Case Theory

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV

Verve Therapeutics downgraded to Hold from Buy at Canaccord

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders

Why Verve Therapeutics Stock Is Skyrocketing Today

Eli Lilly Strikes up to $1.3 Billion Deal to Buy Verve Therapeutics

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B

How To Earn $500 A Month From La-Z-Boy Stock Ahead Of Q4 Earnings